| Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range T Battelino, T Danne, RM Bergenstal, SA Amiel, R Beck, T Biester, E Bosi, ... Diabetes care 42 (8), 1593-1603, 2019 | 4375 | 2019 |
| International consensus on use of continuous glucose monitoring T Danne, R Nimri, T Battelino, RM Bergenstal, KL Close, JH DeVries, ... Diabetes care 40 (12), 1631-1640, 2017 | 2442 | 2017 |
| The CTLA-4 Gene Region of Chromosome 2q33 Is Linked to, and Associated with, Type 1 Diabetes L Nisticò, R Buzzetti, LE Pritchard, B Van der Auwera, C Giovannini, ... Human molecular genetics 5 (7), 1075-1080, 1996 | 1068 | 1996 |
| Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring D Deiss, J Bolinder, JP Riveline, T Battelino, E Bosi, N Tubiana-Rufi, ... Diabetes care 29 (12), 2730-2732, 2006 | 757 | 2006 |
| Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin E Bosi, RP Camisasca, C Collober, E Rochotte, AJ Garber Diabetes care 30 (4), 890-895, 2007 | 738 | 2007 |
| Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. S Trembleau, G Penna, E Bosi, A Mortara, MK Gately, L Adorini The Journal of experimental medicine 181 (2), 817-821, 1995 | 564 | 1995 |
| Increased intestinal permeability precedes clinical onset of type 1 diabetes E Bosi, L Molteni, MG Radaelli, L Folini, I Fermo, E Bazzigaluppi, ... Diabetologia 49 (12), 2824-2827, 2006 | 515 | 2006 |
| MeDuSa: a multi-draft based scaffolder E Bosi, B Donati, M Galardini, S Brunetti, MF Sagot, P Lió, P Crescenzi, ... Bioinformatics 31 (15), 2443-2451, 2015 | 469 | 2015 |
| Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study G Calori, G Lattuada, L Piemonti, MP Garancini, F Ragogna, M Villa, ... Diabetes care 34 (1), 210-215, 2011 | 440 | 2011 |
| Consensus recommendations for the use of automated insulin delivery technologies in clinical practice M Phillip, R Nimri, RM Bergenstal, K Barnard-Kelly, T Danne, R Hovorka, ... Endocrine reviews 44 (2), 254-280, 2023 | 405 | 2023 |
| Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes M Battaglia, S Ahmed, MS Anderson, MA Atkinson, D Becker, PJ Bingley, ... Diabetes care 43 (1), 5-12, 2020 | 385 | 2020 |
| Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy F Ciceri, A Castagna, P Rovere-Querini, F De Cobelli, A Ruggeri, L Galli, ... Clinical immunology 217, 108509, 2020 | 353 | 2020 |
| Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. E Bonifacio, V Lampasona, S Genovese, M Ferrari, E Bosi Journal of immunology (Baltimore, Md.: 1950) 155 (11), 5419-5426, 1995 | 349 | 1995 |
| High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes R Buzzetti, S Di Pietro, A Giaccari, A Petrone, M Locatelli, C Suraci, ... Diabetes care 30 (4), 932-938, 2007 | 326 | 2007 |
| Fatty liver index and mortality: the Cremona study in the 15th year of follow‐up G Calori, G Lattuada, F Ragogna, MP Garancini, P Crosignani, M Villa, ... Hepatology 54 (1), 145-152, 2011 | 307 | 2011 |
| Comparative genome-scale modelling of Staphylococcus aureus strains identifies strain-specific metabolic capabilities linked to pathogenicity E Bosi, JM Monk, RK Aziz, M Fondi, V Nizet, BØ Palsson Proceedings of the National Academy of Sciences 113 (26), E3801-E3809, 2016 | 298 | 2016 |
| Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity E Bonifacio, S Genovese, S Braghi, E Bazzigaluppi, Y Lampasona, ... Diabetologia 38 (7), 816-822, 1995 | 267 | 1995 |
| Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study R De Lorenzo, C Conte, C Lanzani, F Benedetti, L Roveri, MG Mazza, ... PloS one 15 (10), e0239570, 2020 | 258 | 2020 |
| Reduction of circulating neutrophils precedes and accompanies type 1 diabetes A Valle, GM Giamporcaro, M Scavini, A Stabilini, P Grogan, E Bianconi, ... Diabetes 62 (6), 2072-2077, 2013 | 255 | 2013 |
| Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment‐naive patients with type 2 diabetes mellitus E Bosi, F Dotta, Y Jia, M Goodman Diabetes, Obesity and Metabolism 11 (5), 506-515, 2009 | 255 | 2009 |
